News & Pubs

Scientific and Medical Publications

2013 Annual Meeting of the American Society of Clinical Oncology (ASCO)

A Phase I Open-Label Study of Ad-RTS-hIL-12, an Adenoviral Vector Engineered to Express hIL-12, in Combination with an Oral Activator Ligand in Subjects with Unresectable Stage III/IV Melanoma
Download PDF